Скачать или смотреть G V Prasad Reveals the FUTURE of AI-Driven Drug Development at Dr. Reddy's Laboratories

In this session at GCC 2025, Prasad from Dr. Reddy’s unpacks the evolving role of technology in pharma—from molecule synthesis to AI-led drug discovery. Speaking to a room full of Global Capability Center (GCC) leaders, he draws parallels between India’s IT sector and pharma, revealing how AI tools like AlphaFold, robotics, and generative simulations are reshaping R&D, particularly in generics.

Prasad also delves into hot-button topics like GLP-1 treatments , the patent battles with big pharma, and why China has outpaced India in biotech innovation. With sharp insight, he challenges India’s tech and pharma sectors to invest deeply in R&D, urging a cultural and infrastructural shift to move beyond execution toward true innovation.

00:00 - Opening Remarks & Hyderabad’s GCC Impact
03:39 - Why Tech Is a Force Multiplier in Pharma
07:30 - AI in Molecule Synthesis & Drug Development
08:19 - Drug Discovery in Silico: From Alphafold to Robotics
10:27 - The GLP-1 Revolution: Mounjaro, Obesity & Dr. Reddy’s Role
12:39 - Generics vs Big Pharma: Innovation or Imitation?
20:27 - China’s Biotech Playbook vs India’s Innovation Gaps
27:58 - Why India Must Invest Boldly in Scientific R&D